SCHEMBL12803333

SCHEMBL12803333

CCOC(=O)c1c(O)nc2cc(F)c(F)cc2c1C.CCOC(=O)c1c(O)nc2cc(F)c(F)cc2c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.44
NR1H3 Q13133 1/20 0.44
SMN1; SMN2 Q16637 5/20 0.43
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 4/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
TSHR P16473 1/20 0.43
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
CYP3A4 P08684 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
HPGD P15428 2/20 0.40
GAA P10253 2/20 0.40
LMNA P02545 2/20 0.40
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3092788 1.00 NR1H2 (0.44) NR1H2NR1H3SMN1; SMN2ALDH1A1KDM4E
SCHEMBL26617741 0.85 TSHR (0.52) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL22256 0.85 TSHR (0.52) NR1H2NR1H3SMN1; SMN2ALDH1A1KDM4E
SCHEMBL30681992 0.85 TSHR (0.52) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL30681993 0.85 TSHR (0.52) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL538913 0.82 TSHR (0.48) NR1H2NR1H3SMN1; SMN2ALDH1A1KDM4E
SCHEMBL3100597 0.81 SMN1; SMN2 (0.40) NR1H2NR1H3SMN1; SMN2ALDH1A1KDM4E
SCHEMBL3012827 0.80 NR1H2 (0.41) NR1H2NR1H3SMN1; SMN2ALDH1A1KDM4E
SCHEMBL20558 0.79 KDM4E (0.47) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL26617516 0.78 SMN1; SMN2 (0.67) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399673-B2 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2013-03-19 US disclosed
US-20120252841-A1 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators DRUNENTHAL GMBH (DE) 2012-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120252841-A1 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators KCNQ1, KCNQ2, KCNJ2 NR1H2 981/4885NR1H3 959/4885SMN1; SMN2 4161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.